{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:24:33Z","timestamp":1761017073273,"version":"3.40.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.yebeh.2014.04.022","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T18:05:38Z","timestamp":1400609138000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Epilepsy-related psychosis: A role for autoimmunity?"],"prefix":"10.1016","volume":"36","author":[{"given":"T.A.","family":"Pollak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.C.","family":"Mellers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.04.022_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1176\/appi.neuropsych.13.4.492","article-title":"Premorbid psychiatric risk factors for postictal psychosis","volume":"13","author":"Alper","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0020","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and Characteristics of Isolated Psychiatric Episodes in Anti-N-Methyl-d-Aspartate Receptor Encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopsych.2013.07.018","article-title":"Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis","volume":"75","author":"Deakin","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-1211(94)00085-B","article-title":"Postictal psychosis: a case control series of 20 patients and 150 controls","volume":"20","author":"Devinsky","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1192\/bjp.152.2.246","article-title":"Post-ictal psychoses. A clinical and phenomenological description","volume":"152","author":"Logsdail","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yebeh.2010.06.027","article-title":"Postictal psychosis","volume":"19","author":"Trimble","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.eplepsyres.2013.03.015","article-title":"Postictal psychosis in temporal lobe epilepsy: risk factors and postsurgical outcome?","volume":"106","author":"Cleary","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.152.2.224","article-title":"Postictal and chronic psychoses in patients with temporal lobe epilepsy","volume":"152","author":"Umbricht","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.eplepsyres.2009.03.017","article-title":"Delusions, illusions and hallucinations in epilepsy: 2. Complex phenomena and psychosis","volume":"85","author":"Elliott","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eplepsyres.2009.03.018","article-title":"Delusions, illusions and hallucinations in epilepsy: 1. Elementary phenomena","volume":"85","author":"Elliott","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yebeh.2012.02.004","article-title":"Postictal psychosis and its electrophysiological correlates in invasive EEG: a case report study and literature review","volume":"23","author":"Kuba","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s007020050199","article-title":"Left temporal rhythmic electrical activity: a correlate for psychosis? A case report","volume":"106","author":"Seeck","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1528-1157.2001.08700.x","article-title":"Acute psychosis during intracranial EEG monitoring: close relationship between psychotic symptoms and discharges in amygdala","volume":"42","author":"Takeda","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0085","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1528-1157.2001.10701.x","article-title":"Progression of postictal to interictal psychosis","volume":"42","author":"Tarulli","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0105","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.04.022_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/epi.12184","article-title":"Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management","volume":"54","author":"Bien","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11910-013-0348-1","article-title":"Antibodies in epilepsy","volume":"13","author":"Correll","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0125","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/epi.12528","article-title":"Investigation of neuronal autoantibodies in two different focal epilepsy syndromes","volume":"55","author":"Ekizoglu","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1460-9568.2010.07349.x","article-title":"Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies","volume":"32","author":"Moscato","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0135","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2014.01.005","article-title":"Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA\/2J mice, lower seizure threshold and induce abnormal behavior","volume":"42","author":"Ganor","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0145","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1468-1331.2011.03609.x","article-title":"Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies","volume":"19","author":"Falip","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0155","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2012.06638.x","article-title":"Autoimmune diseases and infections as risk factors for schizophrenia","volume":"1262","author":"Benros","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0920-9964(94)90004-3","article-title":"Increased prevalence of antibrain antibodies in the sera from schizophrenic patients","volume":"14","author":"Henneberg","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2013.07.029","article-title":"A systematic, quantitative review of blood autoantibodies in schizophrenia","volume":"150","author":"Ezeoke","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biopsych.2013.07.040","article-title":"Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective","volume":"75","author":"Coutinho","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0185","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0190","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0200","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-5-31","article-title":"In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction","volume":"5","author":"Manto","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0210","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0022-3565(25)10607-1","article-title":"Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation","volume":"274","author":"Liu","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","article-title":"Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study","volume":"162","author":"Rowland","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","author":"Pollak","year":"2013","journal-title":"Psychol Med"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0225","first-page":"S6","article-title":"Anti Neuronal Cell Surface Antibodies as a Cause of Schizophrenia, in 14th International Congress on Schizophrenia Research (ICOSR)","author":"Lennox","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.psychres.2012.09.035","article-title":"A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder","volume":"208","author":"Choe","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/NRL.0b013e318247b87d","article-title":"Glutamic acid decarboxylase autoantibody syndrome presenting as schizophrenia","volume":"18","author":"Najjar","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1399-5618.2012.01028.x","article-title":"Antibodies to the glutamate receptor in mania","volume":"14","author":"Dickerson","year":"2012","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0245","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.0b013e318258300d","article-title":"IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment","volume":"78","author":"Pruss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0255","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0883073813501875","article-title":"Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis: An Unusual Cause of Autistic Regression in a Toddler","volume":"29","author":"Scott","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0260","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(11)60548-5","article-title":"Late onset autism and anti-NMDA-receptor encephalitis","volume":"378","author":"Creten","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","author":"Hammer","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0270","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0280","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.23567","article-title":"Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage","volume":"72","author":"Librizzi","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0285","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/NEN.0b013e31826809a6","article-title":"IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood-brain barrier disruption","volume":"71","author":"Michalak","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0290","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2013.07.006","article-title":"Intracellular and circulating neuronal antinuclear antibodies in human epilepsy","volume":"59","author":"Iffland","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0295","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0300","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/neu.2008.0738","article-title":"Validation of serum markers for blood-brain barrier disruption in traumatic brain injury","volume":"26","author":"Blyth","year":"2009","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2010.08.036","article-title":"Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study","volume":"484","author":"Lu","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0310","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2012.10.012","article-title":"Elevated serum S-100B levels in children with temporal lobe epilepsy","volume":"22","author":"Calik","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0315","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1034\/j.1600-0404.2003.00159.x","article-title":"Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy","volume":"108","author":"Portela","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0320","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2008.05.006","article-title":"Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study","volume":"81","author":"Palmio","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0325","doi-asserted-by":"crossref","first-page":"e56805","DOI":"10.1371\/journal.pone.0056805","article-title":"Consequences of repeated blood-brain barrier disruption in football players","volume":"8","author":"Marchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0330","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0335","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0340","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pruss","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0345","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.0b013e3182a9f531","article-title":"Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report","volume":"81","author":"Leypoldt","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2013","journal-title":"Mov Disord"},{"issue":"Suppl. 9","key":"10.1016\/j.yebeh.2014.04.022_bb0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1167.2007.01394.x","article-title":"Psychosis in epilepsy patients","volume":"48","author":"Nadkarni","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0360","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/01.WNL.0000031429.25067.64","article-title":"Postictal psychosis after temporal lobectomy","volume":"59","author":"Christodoulou","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0365","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/jnnp.56.3.277","article-title":"Post-ictal psychosis after right temporal lobectomy","volume":"56","author":"Manchanda","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0370","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2012.05.005","article-title":"Pre-surgical predictors for psychiatric disorders following epilepsy surgery in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis","volume":"102","author":"Filho","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0375","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/jnnp.2003.022392","article-title":"Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors","volume":"75","author":"Shaw","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/WNL.62.1.110","article-title":"Delusional state following acute stroke","volume":"62","author":"Kumral","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00385660","article-title":"Systematic EEG follow-up study of traumatic psychosis","volume":"237","author":"Koufen","year":"1987","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"10.1016\/j.yebeh.2014.04.022_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2011.11.029","article-title":"Proposition: limbic encephalitis may represent limbic status epilepticus. A review of clinical and EEG characteristics","volume":"24","author":"Kaplan","year":"2012","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:01:18Z","timestamp":1746230478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":78,"alternative-id":["S1525505014001541"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.04.022","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy-related psychosis: A role for autoimmunity?","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}